Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

Mouse Anti-EZH1 Recombinant Antibody (CBT3068) (V2LY-0625-LY1187)


See all EZH1 antibodies
Online Inquiry
Tested Data
Mouse Anti-EZH1 Recombinant Antibody (CBT3068) (V2LY-0625-LY1187) in ELISA
Mouse Anti-EZH1 Recombinant Antibody (CBT3068) (V2LY-0625-LY1187) in ELISA
Mouse Anti-EZH1 Recombinant Antibody (CBT3068) (V2LY-0625-LY1187) in WB
Mouse Anti-EZH1 Recombinant Antibody (CBT3068) (V2LY-0625-LY1187) in WB
Mouse Anti-EZH1 Recombinant Antibody (CBT3068) (V2LY-0625-LY1187) in WB
Mouse Anti-EZH1 Recombinant Antibody (CBT3068) (V2LY-0625-LY1187) in WB
Mouse Anti-EZH1 Recombinant Antibody (CBT3068) (V2LY-0625-LY1187) in WB
Mouse Anti-EZH1 Recombinant Antibody (CBT3068) (V2LY-0625-LY1187) in WB
Mouse Anti-EZH1 Recombinant Antibody (CBT3068) (V2LY-0625-LY1187) in FC
Mouse Anti-EZH1 Recombinant Antibody (CBT3068) (V2LY-0625-LY1187) in FC

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBT3068
Antibody Isotype
IgG1
Application
WB, FC

Basic Information

Immunogen
Purified recombinant fragment of human EZH1 (AA: 135-294) expressed in E. Coli.
Host Species
Mouse
Specificity
Human
Antibody Isotype
IgG1
Clonality
Monoclonal Antibody
Application Notes
ApplicationNote
WB1:500-1:2,000
FC1:200-1:400
ELISA1:10,000

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS
Preservative
Sodium azide
Concentration
Batch dependent
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
Enhancer Of Zeste 1 Polycomb Repressive Complex 2 Subunit
Entrez Gene ID
2145
UniProt ID
Q92800
Research Area
Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH1 complex, which methylates 'Lys-27' of histone H3, leading to transcriptional repression of the affected target gene. Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Required for embryonic stem cell derivation and self-renewal, suggesting that it is involved in safeguarding embryonic stem cell identity. Compared to EZH2-containing complexes, it is less abundant in embryonic stem cells, has weak methyltransferase activity and plays a less critical role in forming H3K27me3, which is required for embryonic stem cell identity and proper differentiation.
Biological Process
Anatomical structure morphogenesis Source: ProtInc
Chromatin remodeling Source: ARUK-UCL
Chromatin silencing at telomere Source: ARUK-UCL
Heterochromatin assembly Source: ARUK-UCL
Hippocampus development Source: Ensembl
Histone H3-K27 methylation Source: InterPro
Negative regulation of transcription by RNA polymerase II Source: ARUK-UCL
Positive regulation of transcription by RNA polymerase II Source: Ensembl
Cellular Location
Nucleus. Colocalizes with trimethylated 'Lys-27' of histone H3.
More Infomation

Jing, R., Scarfo, I., Najia, M. A., da Rocha, E. L., Han, A., Sanborn, M., ... & Daley, G. Q. (2022). EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity. Cell Stem Cell, 29(8), 1181-1196.

Grau, D., Zhang, Y., Lee, C. H., Valencia-Sánchez, M., Zhang, J., Wang, M., ... & Armache, K. J. (2021). Structures of monomeric and dimeric PRC2: EZH1 reveal flexible modules involved in chromatin compaction. Nature communications, 12(1), 1-12.

Kusakabe, Y., Chiba, T., Oshima, M., Koide, S., Rizq, O., Aoyama, K., ... & Kato, N. (2021). EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma. Scientific reports, 11(1), 1-14.

El Said, N. H., Della Valle, F., Liu, P., Paytuví-Gallart, A., Adroub, S., Gimenez, J., & Orlando, V. (2021). Malat-1-PRC2-EZH1 interaction supports adaptive oxidative stress dependent epigenome remodeling in skeletal myotubes. Cell death & disease, 12(10), 1-10.

Kagiyama, Y., Fujita, S., Shima, Y., Yamagata, K., Katsumoto, T., Nakagawa, M., ... & Kitabayashi, I. (2021). CDKN1C‐mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib. Cancer Science, 112(6), 2314-2324.

Lau-Corona, D., Bae, W. K., Hennighausen, L., & Waxman, D. J. (2020). Sex-biased genetic programs in liver metabolism and liver fibrosis are controlled by EZH1 and EZH2. PLoS genetics, 16(5), e1008796.

Wassef, M., Luscan, A., Aflaki, S., Zielinski, D., Jansen, P. W., Baymaz, H. I., ... & Margueron, R. (2019). EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer. Proceedings of the National Academy of Sciences, 116(13), 6075-6080.

Jung, C. K., Kim, Y., Jeon, S., Jo, K., Lee, S., & Bae, J. S. (2018). Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors. Human Pathology, 81, 9-17.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-EZH1 Recombinant Antibody (CBT3068)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Learn more

Documents

Request bulk or custom quote
Second antibody and isotype control

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Online Inquiry